Vial, a global tech-first CRO providing next-generation clinical trial management services, announced it will be sponsoring and presenting at the 2023 Clinical Trials at the Summit (CTS) in Park City, UT, Saturday, June 10.
CTS 2023 will be taking place at the Pendry Park City. The event unites a global panel of specialists to delve into the progress of ongoing clinical trials and the most recent data, with the ultimate objective of advancing vitreoretinal care. CTS aims to examine the essential collaborations and tactics necessary to successfully design and implement impactful clinical trials. The event is founded by Arshad M. Khanani, MD, MA, Managing Partner, Director of Clinical Research, and Director of Fellowship at Sierra Eye Associates. Dr. Khanani is also a part of Vial’s scientific advisory board for their Ophthalmology CRO.
During CTS 2023, Vial’s VP of Ophthalmology, Amy Del Medico, will present over, “Reimagining Clinical Trials: Enabling Trials to Run Efficiently Powered by Technology.” Vial’s CEO and Co-founder, Simon Burns, and John Sheperdson, Associate Business Development Director, will also be attending the event.
“We are honored to sponsor and present at CTS 2023. Our team is thankful for Dr. Khanani’s invitation and the opportunity to showcase Vial’s tech-first approach to reimagining clinical trials,” said Simon Burns, CEO and Co-founder of Vial.
Visit AITechPark for cutting-edge Tech Trends around AI, ML, Cybersecurity, along with AITech News, and timely updates from industry professionals!
